Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where Jun Ohsumi is active.

Publication


Featured researches published by Jun Ohsumi.


FEBS Letters | 1991

Molecular cloning of cDNA encoding adipogenesis inhibitory factor and identity with interleukin‐11

Ichiro Kawashima; Jun Ohsumi; Katsuko Mita-Honjo; Kumi Shimoda-Takano; Hiroko Ishikawa; Sachiko Sakakibara; Kenji Miyadai; Yo Takiguchi

A cDNA encoding a novel adipogenesis inhibitory factor (AGIF) that inhibits the process of adipogenesis in mouse 3T3‐L1 preadipocytes was cloned from a cDNA library of the human bone marrow‐derived stromal cell line KM‐102. The cloned cDNA contains an open reading frame coding for an AGIF precursor of 199 amino acids. Analysis of the sequence of this cDNA revealed identity of this factor with a recently reported novel cytokine, designated interleukin‐11 (IL‐11). AGIF/IL‐11 may play an important role in stromal cell‐associated hematopoiesis through its regulatory action on adipocyte differentiation in the bone marrow microenvironment.


FEBS Letters | 1991

Adipogenesis inhibitory factor A novel inhibitory regulator of adipose conversion in bone marrow

Jun Ohsumi; Kenji Miyadai; Ichiro Kawashima; Hiroko Ishikawaohsumi; Sachiko Sakakibara; Katsuko Mita-Honjo; Yo Takiguchi

Recombinant adipogenesis inhibitory factor (AGIF) was purified to homogeneity from the conditioned medium of COS‐1 cells transfected with human AGIF cDNA. The amino‐terminal sequence analysis of the mature AGIF revealed that AGIF was produced as a precursor consisting of 199 amino acids and processed into a mature form of 178 amino acids by a cleavage between Ala(−1) and Pro(+1). The purified AGIF inhibited the process of adipogenesis in mouse 3T3‐L1 preadipocytes, indicating that AGIF directly acts on the cells. AGIF acted as an adipogenic antagonist not only on the extramedullary cell line 3T3‐L1 but also on the mouse bone marrow stroma‐derived cell line H‐I/A, suggesting that this cytokine may regulate adipogenesis in bone marrow.


Archive | 1989

Method of treating cachexia

Yo Takiguchi; Jun Ohsumi; Yasuo Shimoji; Kazuhiko Sasagawa


Bioscience, Biotechnology, and Biochemistry | 1996

Importance of the Carboxy-terminus of Human Interleukin-11 in Conserving Its Biological Activity

Kenji Miyadai; Jun Ohsumi; Chigusa Yoshimura; Ichiro Kawashima; Yasuhiro Ito


Journal of pharmacobio-dynamics | 1991

NOVEL ADIPOGENESIS INHIBITORY FACTOR (AGIF) : ITS STRUCTURE AND FUNCTION

Ichiro Kawashima; Jun Ohsumi; Kenji Miyadai; Katsuko Mita-Honjo; Hiroko Ishikawaohsumi; Sachiko Sakakibara; Kumi Shimoda-Takano; Yo Takiguchi


Archive | 1989

Method for the treatment of cachexia and certain applicable for connections.

Yo Takiguchi; Jun Ohsumi; Yasuo Shimoji; Kazuhiko Sasagawa


Archive | 1989

Method for treatment of cachexia and specific for it to be applied compounds.

Yo Takiguchi; Jun Ohsumi; Yasuo Shimoji; Kazuhiko Sasagawa


Archive | 1989

Neue Triazolopyrimidin- und Pyrazolopyrimidinderivate zur Behandlung von Kachexie. New triazolopyrimidine and Pyrazolopyrimidinderivate for the treatment of cachexia.

Yo Takiguchi; Jun Ohsumi; Yasuo Shimoji; Kazuhiko Sasagawa


Archive | 1989

New triazolopyrimidine and Pyrazolopyrimidinderivate for the treatment of cachexia.

Yo Takiguchi; Jun Ohsumi; Yasuo Shimoji; Kazuhiko Sasagawa


Archive | 1986

Menschliche bauchspeichelelastase. Human bauchspeichelelastase.

Yo Takiguchi; Ichiro Kawashima; Hidehiko C O Bio-Scie Eurukawa; Toshinori Ohmine; Jun Ohsumi

Collaboration


Dive into the Jun Ohsumi's collaboration.

Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar

Yasuhiro Ito

National Agriculture and Food Research Organization

View shared research outputs
Researchain Logo
Decentralizing Knowledge